| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
252,000 |
123,229 |
$15.29M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
226,014 |
106,147 |
$4.27M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
127,377 |
66,320 |
$2.65M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
20,781 |
13,360 |
$765K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,645 |
1,177 |
$76K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
217 |
141 |
$7K |
| 0124A |
|
81 |
81 |
$3K |
| 0004A |
|
83 |
83 |
$3K |
| 90686 |
|
77 |
76 |
$2K |
| 0134A |
|
26 |
26 |
$1K |
| 0074A |
|
18 |
18 |
$720.00 |
| 0071A |
|
16 |
16 |
$620.00 |
| 0064A |
|
13 |
13 |
$500.00 |
| 80061 |
Lipid panel |
22 |
17 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
22 |
17 |
$0.00 |
| 82607 |
|
21 |
17 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
22 |
17 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22 |
17 |
$0.00 |